Krista Burke

Springhouse — United States

Medicine · Health Sciences

5h-index288citations33works0.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(23), Cancer Treatment and Pharmacology(22), Angiogenesis and VEGF in Cancer(21), Peptidase Inhibition and Analysis(4), Cancer Immunotherapy and Biomarkers(3)

Publications33 total

Supplementary Table 6 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 7 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 6 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 7 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 2 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 4 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 1 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 1 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 8 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 3 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 14 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 2 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 4 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 13 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 3 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 5 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 5 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 11 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Data from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 10 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
page 1 of 2Next →

Frequent Co-authors

Shalom D. Goldberg(23), Tero Satomaa(23), Olulanu H. Aina(23), Olli Aitio(23), Vadim Dudkin(23), Brian Geist(23), Onyi Irrechukwu(23), Anna‐Liisa Hänninen(23), Annamari Heiskanen(23), Jari Helin(23), Jukka O. Hiltunen(23), Jacqueline Kinyamu-Akunda(23), Donna M. Klein(23), Neeraj Kohli(23), Titta Kotiranta(23), Tuula Lähteenmäki(23), Ritva Niemelä(23), Virve Pitkänen(23), Henna Pynnönen(23), William Rittase(23)